Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Oct 15;331(7521):895-7.
doi: 10.1136/bmj.331.7521.895.

Disappointing biotech

Roberta Joppi  1 , Vittorio Bertele', Silvio Garattini
Affiliations
Review

Disappointing biotech

Roberta Joppi et al. BMJ. .

Abstract

Biotechnology offered the hope of cheaper and better drugs. Analysis of biotech products licensed in Europe shows the reality is somewhat different

PubMed Disclaimer

Figures

Figure 1
Figure 1
Methodological characteristics of clinical trials supporting licence application for biotechnological drugs. Numbers in square brackets indicate innovative drugs
See this image and copyright information in PMC

Comment in

References

    1. European Parliament and Council of the European Union. Regulation (EC) No 726/2004 of 31 March 2004. http://pharmacos.eudra.org/F2/eudralex/vol-1/REG_2004_726/REG_2004_726_E... (accessed 2 Feb 2005).
    1. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease. N Engl J Med 2001;345: 9-16 - PubMed
    1. Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP, et al. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. Lancet 1997;350: 1193-8. - PubMed
    1. Eriksson BI, Ekman S, Kalebo P, Zachrisson B, Bach D, Close P, et al. Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393. Lancet 1996;347: 635-9. - PubMed
    1. Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, et al. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 2001;97: 2998-3003. - PubMed